retatrutide maintenance dose A Clinician's Guide to Dosing Retatrutide Dosage for Weight Loss

Barriers to Use These highly effective weight loss medications are not covered or not affordably covered by almost all insurance

Glucagon and GLP- 1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

doi: 10.1161/CIRCULATIONAHA.121.055459

Yet payers historically have not cross-covered

**Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program

With comprehensive 3, 6, and 12-month usage plans, daily integration support, and sustainable habit-building guidance, HealthRX transforms the weight loss journey from an insurance-dependent struggle to an accessible, results-driven investment in long-term health and wellness